935 related articles for article (PubMed ID: 15578450)
21. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
22. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
Larson LJ; Schultz RD
Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
[TBL] [Abstract][Full Text] [Related]
23. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
24. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
25. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine.
Krakowka S; Olsen RG; Axthelm MK; Rice J; Winters K
J Am Vet Med Assoc; 1982 Jan; 180(2):137-9. PubMed ID: 7061309
[TBL] [Abstract][Full Text] [Related]
26. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus.
Pollock RV; Carmichael LE
Am J Vet Res; 1983 Feb; 44(2):169-75. PubMed ID: 6299142
[TBL] [Abstract][Full Text] [Related]
27. Duration of immunity in red wolves (Canis rufus) following vaccination with a modified live parvovirus and canine distemper vaccine.
Anderson K; Case A; Woodie K; Waddell W; Reed HH
J Zoo Wildl Med; 2014 Sep; 45(3):550-4. PubMed ID: 25314821
[TBL] [Abstract][Full Text] [Related]
28. Effect of recombinant canine distemper vaccine on antibody titers in previously vaccinated dogs.
Larson LJ; Hageny TL; Haase CJ; Schultz RD
Vet Ther; 2006; 7(2):107-12. PubMed ID: 16871492
[TBL] [Abstract][Full Text] [Related]
29. Assessing demographic and epidemiologic parameters of rural dog populations in India during mass vaccination campaigns.
Belsare AV; Gompper ME
Prev Vet Med; 2013 Aug; 111(1-2):139-46. PubMed ID: 23664490
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
[TBL] [Abstract][Full Text] [Related]
31. Response of puppies to canine-origin parvovirus vaccines.
Carmichael LE; Pollock RV; Joubert JC
Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
[TBL] [Abstract][Full Text] [Related]
32. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
[TBL] [Abstract][Full Text] [Related]
33. Effect of vaccination with recombinant canine distemper virus vaccine immediately before exposure under shelter-like conditions.
Larson LJ; Schultz RD
Vet Ther; 2006; 7(2):113-8. PubMed ID: 16871493
[TBL] [Abstract][Full Text] [Related]
34. Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit.
Killey R; Mynors C; Pearce R; Nell A; Prentis A; Day MJ
J Small Anim Pract; 2018 Jan; 59(1):27-31. PubMed ID: 29087557
[TBL] [Abstract][Full Text] [Related]
35. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
36. Serologic response of maned wolves (Chrysocyon brachyurus) to canine and canine parvovirus vaccination distemper virus.
Maia OB; Gouveia AM
J Zoo Wildl Med; 2001 Mar; 32(1):78-80. PubMed ID: 12790399
[TBL] [Abstract][Full Text] [Related]
37. Challenge studies for registration of canine core vaccines: is it time to update the European Pharmacopeia?
Decaro N; Elia G; Buonavoglia C
Vet Microbiol; 2020 May; 244():108659. PubMed ID: 32402341
[No Abstract] [Full Text] [Related]
38. Effects of subclinical inflammation on C-reactive protein and haptoglobin levels as well as specific humoral immunity in dogs vaccinated against canine distemper and parvovirus.
Romiszewski P; Kostro K; Lisiecka U
BMC Vet Res; 2018 Mar; 14(1):70. PubMed ID: 29506502
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.
Coyne MJ
Vet Ther; 2000; 1(1):35-42. PubMed ID: 19757563
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
